Trial Profile
Test-retest reproducibility of PET scan with adenosine A2A receptor ligand [C-11]Preladenant in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2022
Price :
$35
*
At a glance
- Drugs Preladenant (Primary)
- Indications Solid tumours
- Focus Pharmacodynamics
- 24 Nov 2022 Status changed from active, no longer recruiting to completed.
- 03 Sep 2021 Status changed from recruiting to active, no longer recruiting.
- 21 Nov 2017 New trial record